STOCK TITAN

International Business Machines Corp SEC Filings

IBM NYSE

Welcome to our dedicated page for International Business Machines SEC filings (Ticker: IBM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

IBM’s filings are renowned for their depth—one 10-K can stretch beyond 300 pages of hybrid-cloud revenue tables, mainframe cycle disclosures and quantum research spend. Finding that single note on Red Hat deferred revenue or tracing executive stock awards across appendices isn’t quick work.

Stock Titan solves the problem in seconds. Our AI-powered summaries turn IBM SEC filings explained simply, flagging the datapoints you search for most: cloud ARR growth, services backlog, and pension impacts. Real-time feeds capture every IBM Form 4 insider transactions real-time, so you never miss when a director buys shares ahead of a zSystems launch.

Need specifics? The list below shows where each form answers common questions investors ask:

  • 10-K / annual report – IBM annual report 10-K simplified reveals segment profit, hybrid cloud momentum and long-term debt structure.
  • 10-Q / quarterly earnings – IBM quarterly earnings report 10-Q filing pairs AI commentary with charts on consulting margin trends.
  • Form 4 – Track IBM insider trading Form 4 transactions to gauge confidence; alerts push IBM executive stock transactions Form 4 within minutes of EDGAR posting.
  • 8-K – IBM 8-K material events explained covers sudden leadership moves or large client wins.
  • DEF 14A – IBM proxy statement executive compensation decodes pay vs. performance math.

From IBM earnings report filing analysis to understanding IBM SEC documents with AI, every disclosure is indexed, summarized and searchable. Stop scrolling through PDFs—compare quarter-over-quarter cloud revenue, monitor insider sentiment, or export data for models, all from one page.

Rhea-AI Summary

Peter R. Voser, an IBM director, reported a non-derivative acquisition dated 09/30/2025 of 355 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. The filing shows a per-share reference price of $282.16 and indicates 30,918 shares beneficially owned by Mr. Voser following the reported transaction. The Promised Fee Shares are deferrals of director fees that are paid out after retirement in common stock or cash, and distribution is deferred until retirement according to the plan terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Martha E. Pollack, an IBM director, reported an acquisition of 209 "Promised Fee Shares" under the IBM Board of Directors Deferred Compensation and Equity Award Plan executed on 09/30/2025. These deferred shares were recorded at a notional price of $282.16 each and are payable in common stock or cash after retirement. After this transaction, the reporting person beneficially owned 16,538 shares of IBM common stock in a direct ownership form. The filing notes the shares represent deferred director fees and that distributions are deferred until retirement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Michael Miebach, a director of International Business Machines Corp (IBM), reported on Form 4 that on 09/30/2025 he elected to defer director fees into Promised Fee Shares under IBM's Board of Directors Deferred Compensation and Equity Award Plan. The deferral converted fees into 324 shares at an indicated per-share price of $282.16. After the transaction, he beneficially owns 3,204 shares directly. The Promised Fee Shares are payable after retirement and the distribution is deferred until that time, per the plan terms; the filing does not state the dollar value of the deferred fee beyond the per-share price or the retirement date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Insider transaction reported by director F. W. McNabb III at IBM (IBM). The Form 4 shows a transaction dated 09/30/2025 in which 324 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan were acquired at an indicated share price of $282.16 and recorded as Common Stock. Following this reported transaction, the reporting person beneficially owned 15,223 shares directly. The filing explains these are Promised Fee Shares arising from deferral of director fees, with distribution deferred until the director's retirement and paid in either common stock or cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Andrew N. Liveris, a director of International Business Machines Corp. (IBM), reported a non-derivative acquisition on 09/30/2025 of 346 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. The filing shows a per-share reference of $282.16 and indicates 42,628 shares beneficially owned by Mr. Liveris following the reported transaction. The Promised Fee Shares are compensation deferrals that are payable after retirement and the distribution is explicitly deferred until retirement. The Form 4 was signed on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Michelle J. Howard, a director of International Business Machines Corp. (IBM), received 292 shares of common stock as Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. The transaction, recorded 09/30/2025, shows the shares were issued at a per-share value of $282.16 and increased her total beneficial ownership to 15,580 shares. The filing explains these Promised Fee Shares represent deferred director fees that are payable after retirement and remain deferred until retirement under the plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Alex Gorsky, an IBM director, reported a non‑derivative acquisition on 09/30/2025 involving 381 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. Those shares were recorded at a per‑share value of $282.16. Following the transaction, Gorsky beneficially owns 32,805 shares of IBM common stock on a direct basis. The filing notes the shares are part of a deferred compensation arrangement and that distribution of the Promised Fee Shares is deferred until retirement. This Form 4 reflects a routine fee deferral by a director rather than an open‑market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marianne C. Brown, a director of International Business Machines Corp (IBM), reported a non-derivative acquisition related to deferred director fees. The Form 4 shows a transaction dated 09/30/2025 in which 324 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan were recorded as acquired at a stated fee/share price of $282.16. Those Promised Fee Shares are payable after retirement and are deferred until retirement. Following this reported transaction, Ms. Brown beneficially owns 2,947 shares of IBM common stock in a direct ownership form. The filing was executed on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Reporting person Nicolas A. Fehring, Vice President and Controller of International Business Machines Corporation (IBM), filed a Form 4 reporting transactions on September 1-2, 2025. The filing shows vested restricted stock units (RSUs) and related share movements: 2,742 RSUs were released and converted to 2,742 shares on 09/01/2025, a sale of 1,388 shares at $243.59 on 09/01/2025, and a disposition of 400 shares on 09/02/2025.

After these transactions the reporting person beneficially owned 13,735.419 shares. The Form 4 explains the RSU grant history (original grant on 09/01/2021 with vesting tranches) and notes certain RSUs are payable in cash or common stock with future vesting dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report

FAQ

What is the current stock price of International Business Machines (IBM)?

The current stock price of International Business Machines (IBM) is $289.46 as of October 8, 2025.

What is the market cap of International Business Machines (IBM)?

The market cap of International Business Machines (IBM) is approximately 273.7B.
International Business Machines Corp

NYSE:IBM

IBM Rankings

IBM Stock Data

273.75B
930.28M
0.12%
65.15%
1.53%
Information Technology Services
Computer & Office Equipment
Link
United States
ARMONK